Skip to main content

Want a detailed portfolio tracker?

Anixa Biosciences (ANIX) P/E (2011 - 2026)

Anixa Biosciences (ANIX) P/E from Jan 31, 2011 to Jul 21, 2026. The TTM Anixa Biosciences (ANIX) P/E is -11.82. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Anixa Biosciences (ANIX)

YearP/EChange
2026-11.82+27.21%
2025-9.29+57.00%
2024-5.92-51.75%
2023-12.27+28.96%
2022-9.51+40.52%
2021-6.77-1.45%
2020-6.87+22.87%
2019-5.59+8.67%
2018-5.14+9.53%
2017-4.70-50.15%
2016-9.42-49.79%
2015-18.76+660.23%
2014-2.47-48.31%
2013-4.78-37.29%
2012-7.61+98.14%
2011-3.84N/A

Comparison Anixa Biosciences (ANIX) P/E with competitors

Anixa Biosciences (ANIX) P/E is -11.82.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.63%
FGENFibroGen Inc0.24-102.03%
CHRSCoherus Biosciences Inc0.85-107.18%
FBIOFortress Biotech Inc0.95-108.03%
ORMPOramed Pharmaceuticals Inc1.50-112.71%
AGENAgenus Inc3.01-125.46%
INVAInnoviva Inc3.15-126.68%
VXRTVaxart Inc3.55-130.02%
CRMDCorMedix Inc3.63-130.69%
CVACCureVac N.V.4.45-137.60%
GLPGGalapagos NV4.86-141.10%
SRPTSarepta Therapeutics Inc4.88-141.29%
ABEOAbeona Therapeutics Inc5.39-145.57%
ABUSArbutus Biopharma Corp5.60-147.33%
ZVRAZevra Therapeutics Inc5.89-149.80%
SPROSpero Therapeutics Inc6.23-152.68%
CGENCompugen Ltd6.31-153.40%
RIGLRigel Pharmaceuticals6.87-158.13%
SLXNSilexion Therapeutics Corp7.30-161.71%
OMEROmeros Corporation9.26-178.31%
AUPHAurinia Pharmaceuticals Inc9.58-181.07%
PLXProtalix BioTherapeutics Inc10.89-192.12%
ACADAcadia Pharmaceuticals Inc11.73-199.20%
TBPHTheravance Biopharma Inc12.26-203.72%
ADMAAdma Biologics Inc12.42-205.04%
HRMYHarmony Biosciences Holdings Inc13.82-216.89%
SABSSAB Biotherapeutics Inc14.14-219.57%
NAGENiagen Bioscience Inc14.82-225.34%
INCYIncyte Corp15.82-233.83%
REGNRegeneron Pharmaceuticals Inc15.86-234.12%
PBYIPuma Biotechnology Inc17.32-246.46%
CPRXCatalyst Pharmaceuticals Inc17.44-247.51%
EXELExelixis Inc17.54-248.34%
TGTXTG Therapeutics Inc18.97-260.42%
MDXGMimedx Group Inc20.55-273.84%
XOMAXOMA Royalty Corp22.87-293.49%
ARGXArgen X SE24.30-305.52%
CTMXCytomX Therapeutics Inc24.82-309.95%
XOMAOXOMA Royalty Corp25.34-314.38%
HALOHalozyme Therapeutics Inc25.62-316.74%
XOMAPXOMA Royalty Corp25.67-317.13%
VRTXVertex Pharmaceuticals Inc27.99-336.79%
RPRXRoyalty Pharma plc - Class A28.69-342.65%
SLNOSoleno Therapeutics Inc29.02-345.43%
ASNDAscendis Pharma A/S30.09-354.48%
LGNDLigand Pharmaceuticals Inc - Class B37.91-420.68%
APLSApellis Pharmaceuticals Inc39.02-430.06%
BMRNBiomarin Pharmaceutical Inc42.21-457.05%
KRYSKrystal Biotech Inc45.34-483.54%
ONCBeiGene Ltd69.54-688.21%
PHARPharming Group N.V.75.03-734.60%
TECHBio-Techne Corp101.96-962.41%
VCELVericel Corp109.92-1029.77%
ALNYAlnylam Pharmaceuticals Inc117.96-1097.81%
GMABGenmab140.29-1286.65%
TLXTelix Pharmaceuticals Ltd162.15-1471.57%
CORTCorcept Therapeutics Inc212.86-1900.45%